Broad details of NO signaling involving NO synthesis by nitric oxide synthase and NO activation of soluble guanylate cyclase (sGC) are reasonably well-understood, though critical molecular aspects of function remain unanswered. On the contrary, relatively little is known about sGC-independent NO signaling. Most sGC- independent hypotheses involve S-nitrosation of low molecular weight thiols or protein thiols. Some speculate that metal-catalyzed oxidation of a thiol and subsequent reaction with NO, thus forming a nitrosothiol, could be playing a major role in this type of signaling. More interesting is the possibility that the thiol could be the nucleophilic amino acid of an important enzyme - for instance, a cysteine protease.
Many important questions must be answered to establish S-nitrosation as a deliberate cellular modification and not a stochastic result of nitrosative stress. Are there enzymes, such as kinases and phosphatases, to nitrosate and denitrosate specific protein targets? The tools needed to answer these questions do not exist. In an effort to begin to understand cellular signaling by protein S-nitrosation, we have recently studied the interaction of thioredoxin (Trx) with caspase 3 (Casp). Casp plays an important role in vivo as the executioner of cellular apoptosis. We showed that Casp may be S-nitrosated at Cys163 by transfer of NO from Cys73 of Trx in vitro and that this nitrosation event inhibits the activity of Casp towards celullar apoptosis in vivo.
Trx has many known binding partners involved in a wide variety of cellular processes, indicating a potential role for Trx in multiple nitrosation pathways. To date, whether Trx transnitrosates other proteins, and how it comes to be endogenously nitrosated on C73, is unknown. We are currently exploring the potential role of Trx as a general regulator of S-nitrosation in vivo, controlling the specificity of nitrosation by binding to, and transnitrosated, downstream targets. We are working to identify both direct and downstream nitrosated targets of Trx-C73-SNO-dependent nitrosation in cells and lysates, and exploring the molecular characterization of Trx-SNO transnitrosation events. We are also studying the in vivo nitrosation of thioredoxin itself, as the identity of the Trx-C73-nitrosating agent is currently unknown. To these ends, we are studying the biology of NO donors both in vitro and in vivo and expanding methodology for identifying S-nitrosated proteins.
References (1) Mitchell, DA; Michel, T; Marletta, MA. Effects of S-nitrosation of nitric oxide synthase. Adv. Exp. Biol. 2007, 1, 151-79. (2) Mitchell, DA.; Morton, SU.; Fernhoff, NB.; Marletta, MA. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc. Nat. Acad. Sci. USA 2007, 104, 11609-14. (3) Mitchell, DA; Morton, SU; Marletta, MA. Design and characterization of an active site selective caspase-3 transnitrosating agent.ACS Chem Biol. 2006, 1, 659-65. (4) Mitchell, DA; Marletta, MA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol. 2005, 1, 154-8 (5) Erwin, PA; Mitchell, DA; Sartoretto, J; Marletta, MA; Michel, T. Subcellular targeting and differential S-nitrosylation of endothelial nitric oxide synthase. J Biol Chem. 2005, 281, 151-7. (6) Mitchell, DA; Erwin, PA; Michel, T; Marletta, MA. S-Nitrosation and regulation of inducible nitric oxide synthase. Biochemistry. 2005, 44, 4636-47. Home │Research │ People │ Publications │Lab Links │Contact Info |